Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BN.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BN.4NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
CK.1.4ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
CK.1.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CK.1.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CK.1.4NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BQ.1.1.11ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BQ.1.1.11ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.1.11ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.1.11NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.4.6.4ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.4.6.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.4.6.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.4.6.4NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BQ.1.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BQ.1.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BQ.1.5ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BQ.1.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.5NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.2.75.5ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.2.75.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.75.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.75.5NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BF.7.8ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BF.7.8ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BF.7.8ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.7.8NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BQ.1.1.40ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BQ.1.1.40ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.1.40ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.1.40NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
DM.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
DM.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
DM.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
DM.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BQ.1.1.60ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BQ.1.1.60ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.1.60ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.1.60NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BQ.1.1.49ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BQ.1.1.49ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.1.49ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.1.49NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
CK.2.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
CK.2.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CK.2.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CK.2.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used